The 2-Minute Rule for factors that affect posology
However, There's a minority of instances wherever the therapy of EID utilizing the ICOC chelation protocol involving DF or L1 or their blend might not be possible due to lower tolerability or toxic side effects such as allergic reactions all through parenteral infusion of DF or toxicity including L1 agranulocytosis (Desk 1). In this sort of cases,